# DESCRIPTION

## TECHNICAL FIELD

- introduce biotechnology field

## BACKGROUND

- introduce cardiovascular diseases
- describe limitations of statins
- introduce PCSK9 and its functions
- describe research on PCSK9
- introduce PCSK9 inhibitors
- describe antibody drugs
- highlight importance of PCSK9 antibody inhibitors

## SUMMARY

- introduce PCSK9 antibody development
- describe difficulties in traditional antibody development
- introduce camel immunization method
- describe phage display technology
- introduce high-affinity antibody screening
- describe antibody structure
- introduce heavy chain variable region
- describe heavy chain framework region
- introduce heavy chain constant region
- describe antibody properties
- introduce nucleic acid molecule
- describe expression vector and recombinant cell

## DESCRIPTION OF EMBODIMENTS

- introduce nanobody
- describe structure of nanobody
- motivate use of camel nanobody
- describe immunization of camels with PCSK9 antigen
- describe antibody with high specificity and high affinity
- provide CDR sequences of heavy chain variable region
- describe conservative amino acid substitutions
- provide heavy chain variable region sequences
- describe nucleic acid molecule encoding antibody
- provide nucleotide sequences of nucleic acid molecule
- describe expression vector and recombinant cell
- describe pharmaceutical composition and kit
- describe pharmaceutical use and method of treatment

### Example 1 Construction of PCSK9 Nanobody Phage Display Library

- immunize camel with PCSK9
- separate blood lymphocyte samples
- extract total RNA and synthesize cDNA
- construct phage display library
- amplify and rescue phage
- detect library diversity
- amplify and rescue phage

### Example 2 Elutriation of PCSK9 Nanobody Using Phage Display Technology

- elutriate PCSK9 nanobody phage library
- amplify and rescue screened phage
- evaluate enrichment of specific antibodies
- identify nanobody positive clones specific for PCSK9
- analyze positive clone sequence
- obtain antibody protein VHH4 sequence
- obtain antibody protein VHH-Z1 sequence
- obtain antibody protein VHH-Z2 sequence
- obtain antibody protein VHH-Z3 sequence
- obtain antibody protein VHH-Z4 sequence
- obtain antibody protein VHH-Z5 to VHH-Z8 sequences

### Example 3 Induced Expression and Purification of PCSK9 Nanobody

- construct PCSK9 nanobody expression bacteria
- induce expression and purify PCSK9 nanobody
- construct VHH-Fc expression vector and express in mammalian cells

### Example 4 Determination of Affinity of PCSK9 Antibody

- analyze affinity of PCSK9 nanobody by ELISA and SPR assays

### Example 5 In Vitro Pharmacodynamic Validation of PCSK9 Antibody on Cancer Cell Model

- validate PCSK9 antibody on cancer cell model

### Example 6 In Vivo Pharmacodynamic Validation of the PCSK9 Antibody in Transgenic Rats

- design pharmacodynamic experiment
- present results of experiment
- clarify scope of disclosure

